Improving the outcome of bone marrow transplantation by using CD 52 monoclonal antibodies to prevent graft-versus-host disease and graft rejection. - Hale,G.; Zhang,M.J.; Bunjes,D.; Prentice,H.G.; Spence,D.; Horowitz,M.M.; Barrett,A.J.; Waldmann,H. (Blood, 1998)